Page last updated: 2024-10-25

ciglitazone and Kahler Disease

ciglitazone has been researched along with Kahler Disease in 2 studies

ciglitazone: structure given in second source; PPAR agonist used for type II diabetes
ciglitazone : An aromatic ether that consists of 1,3-thiazolidine-2,4-dione with position 5 substituted by a 4-[(1-methylcyclohexyl)methoxy]benzyl group. A selective PPARgamma agonist.

Research Excerpts

ExcerptRelevanceReference
"We transduced multiple myeloma cells with a lentivirus-expressing PPARgamma and studied the involvement of this receptor on cell growth and viability."1.35Peroxisome proliferator-activated receptor gamma overexpression suppresses growth and induces apoptosis in human multiple myeloma cells. ( Bernstein, SH; Garcia-Bates, TM; Phipps, RP, 2008)
"Multiple myeloma is essentially an incurable malignancy and it is therefore of great interest to develop new therapeutic approaches."1.32Human multiple myeloma cells express peroxisome proliferator-activated receptor gamma and undergo apoptosis upon exposure to PPARgamma ligands. ( Bernstein, SH; Phipps, RP; Ray, DM, 2004)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Garcia-Bates, TM1
Bernstein, SH2
Phipps, RP2
Ray, DM1

Other Studies

2 other studies available for ciglitazone and Kahler Disease

ArticleYear
Peroxisome proliferator-activated receptor gamma overexpression suppresses growth and induces apoptosis in human multiple myeloma cells.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2008, Oct-15, Volume: 14, Issue:20

    Topics: Apoptosis; Blotting, Western; Bone Marrow Cells; Caspases; Cell Cycle; Cell Proliferation; Cells, Cu

2008
Human multiple myeloma cells express peroxisome proliferator-activated receptor gamma and undergo apoptosis upon exposure to PPARgamma ligands.
    Clinical immunology (Orlando, Fla.), 2004, Volume: 113, Issue:2

    Topics: Apoptosis; Blotting, Western; Caspases; Cell Line, Tumor; Enzyme Activation; Humans; Immunohistochem

2004